This morning, Chardan Healthcare Acquisition Corp. (CHACU) filed for a $70 million, Chardan-backed SPAC focusing on Healthcare companies in North America. Chardan Healthcare will be led by senior members of Chardan Capital Markets, a veteran SPAC underwriter.
Gbola Amusa, who has served as Partner, Director of Research, and Head of Healthcare Equity Research at Chardan Capital Markets since December 2014, will be Chairman of the Board for this team and Jonas Grossman, the current Partner and Head of Capital Markets for Chardan, will be leading as President and CEO. Finally, George Kaufman, who is currently Managing Director and Head of Investment Banking, will be CFO and Head of Strategy.
Looking at this SPAC’s structure, these terms look very aggressive. Of the five deals currently on file (CF Finance, Monocle, Schultze, Andina III, Chardan Healthcare), only Chardan Healthcare is offering a 1/2 share in their warrant. AND, it’s the only SPAC on file with a 24 month life. On top of that, the warrant trigger to call the warrants for redemption is set at >$16.00, rather than the standard >$18.00. (We’ll be putting together a comparison of all five, shortly)
Additionally, you will also notice that the underwriting fee is not being split as upfront/deferred. That’s because Chardan has decided to take a flat fee of just $500K, which makes sense since this is their deal and by lowering the underwriting fee, it reduces the amount of at-risk capital needed to bring the trust to 100%. However, they are purchasing their at-risk capital warrants at $0.40.
Since there is a conflict of interest with Chardan Capital Markets underwriting a SPAC with Chardan as a sponsor, Chardan Healthcare will be utilizing B. Riley FBR as their Qualified Independent Underwriter, but again, just like CF Finance, the QIU is not on the cover. That’s branding, folks. Both Chardan and Cantor want their deals to be 100% their own.
It remains to be seen if Chardan Healthcare will stick with these terms given the comparison to the other four SPACs currently on file. It’s aggressive for sure, but it’s a lot easier to start high rather than work your way up from low.
Chardan is sole book-running manager.
Loeb & Loeb LLP and Schiff Hardin LLP are issuer’s counsel and underwriter’s counsel, respectively.
At the SPAC of Dawn The SPAC market could be primed to wake up from its Turkey Day slumber with a bang this week as both Shepherd Ave (NASDAQ:SPHAU) and Tavia (NASDAQ:TAVIU) have lined up to IPO and five more SPACs have scheduled votes. Late Friday also saw the Future Vision II (NASDAQ:FVNNU) announce a...
Terms Tracker for the Week Ending November 29, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. This was a shortened holiday week, but SPACs still managed to put through a number of filings, which should usher in a busy first half...
Range Capital Acqusition Corp. (NASDAQ:RANGU) has filed to launch a $100 million SPAC with a broad approach, but with expertise in natural resources. The vehicle becomes the fourth SPAC that underwriter EarlyBirdCapital has put its name on so far this year, but it bears some different features than the rest of its 2024 slate. EarlyBirdCapital...
This holiday season is set to be an exciting one in the SPAC world as 10 sponsors and 11 de-SPAC’d companies can expect the gift of a lock-up expiration to mark it with. This makes it the busiest month for such activity in the second half of the year and at least a few parties...
At the SPAC of Dawn For Black Friday’s truncated trading session today, the broader action is likely to be focused on consumer stocks as investors gauge the scope of this year’s holiday spending surge. But, much of this will pass right by SPACs, because consumer has been a sector that has stymied teams more often...